Penumbra (PEN) EBT Growth (3y) (2017 - 2026)
Penumbra (PEN) EBT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 17.92% |
| 10 | Penumbra | 12.79 Bn | 12.13 Bn | 264.94 Mn | 33.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.22% |
| Mar 31, 2026 | 68.90% |
| Dec 31, 2025 | 107.44% |
| Sep 30, 2025 | 158.34% |
| Jun 30, 2025 | 244.33% |
| Mar 31, 2025 | 119.62% |
| Dec 31, 2024 | 45.54% |
| Sep 30, 2024 | 72.26% |
| Jun 30, 2024 | -112.77% |
| Mar 31, 2024 | 5.47% |
| Dec 31, 2023 | 324.83% |
| Sep 30, 2023 | 38.80% |
| Jun 30, 2023 | 46.55% |
| Mar 31, 2023 | 138.68% |
| Dec 31, 2022 | -15.34% |
| Sep 30, 2022 | -38.37% |
| Jun 30, 2022 | -27.78% |
| Mar 31, 2022 | -34.42% |
| Dec 31, 2021 | -96.37% |
| Sep 30, 2021 | 33.72% |